Provided by Tiger Trade Technology Pte. Ltd.

Credit Suisse Holdings

2,489.87
+20.070.81%
Number of Gainers:63
Number of Losers:34
Number of Flat:- -
PE:- -
High:2,490.78
Open:2,469.80
Low:2,469.80
Close:2,469.81
Volume:629.94M
Turnover:133.43B
Market Cap:52.13T
Float Cap:48.77T

Loading ...

Trump Presses Powell to Quit Fed Board Seat Over Headquarters Renovation Cost Overruns

Stock News
·
Oct 01

Market Chatter: Alphabet's Google Staff Question Gemini 4 Performance Despite Strong Benchmarks

MT Newswires Live
·
Oct 01

Microsoft Science President Peter Lee to Step Down - the Information

Reuters
·
Oct 01

US Stocks Mixed as August Inflation Cools; Google Unveils Gemini 4 Argon Model

Stock News
·
Oct 01

Google Announces Gemini 4 Flagship AI Model After Months of Delays

Reuters
·
Oct 01

Primer: NVIDIA Corp (NVDA US) - Oct 2026

Smartkarma
·
Oct 01

BlackRock Group Ceases to Be Substantial Shareholder in ALS Ltd

TIPRANKS
·
Oct 01

Google Shows It's not Out of the AI Race Just Yet

Dow Jones
·
Oct 01

Overnight News for October 1: Trump Pressures Powell to Resign Again, Paramount Issues $30 Billion in Bonds, US August Inflation Below Expectations, Goldman Sachs Delays Rate Hike Forecast to December

Deep News
·
Oct 01

Eli Lilly Says Foundayo Drug Helped Patients Lose Weight in Phase 3 Trial

Dow Jones
·
Oct 01

Tech CEOs Privately Questioned Amodei for Sounding AI Alarm Bells

Dow Jones
·
Oct 01

Fed Approves Stress Test Overhaul in 6-1 Vote: Capital Requirement Volatility Cut in Half, Lone Dissenter Warns Resilience Weakened

Deep News
·
Oct 01

US Defense Secretary: Musk, Palmer Luckey, and Newt Gingrich to Help Pentagon Advance War Plans

Deep News
·
Oct 01

Analysts Are Bullish on These NA Stocks: Moleculin Biotech (MBRX), Alphabet Class A (GOOGL)

TIPRANKS
·
Oct 01

Eli Lilly’s Foundayo shows cardiovascular safety in type 2 diabetes study

TIPRANKS
·
Oct 01

Lilly's Oral Glp-1, Foundayo (Orforglipron), Demonstrated Cardiovascular Safety Alongside Sustained A1c Reduction and Weight Loss in Its Largest and Longest Type 2 Diabetes Study

THOMSON REUTERS
·
Oct 01

Eli Lilly - Achieve-4: Foundayo Shows 16% Lower Mace-4 and 23% Lower Mace-3 Risk vs Insulin Glargine

THOMSON REUTERS
·
Oct 01

Eli Lilly - Foundayo Shows Smaller Egrf Reduction and Greater Albuminuria Reduction vs Insulin Glargine

THOMSON REUTERS
·
Oct 01

Neptune Insurance Names David Noble Independent Director

Reuters
·
Oct 01

NASD Most Active Issues

Dow Jones
·
Oct 01